Please try another search
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also provides top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Christopher D. J. Pearce | 69 | 1994 | Non Executive Chairman |
Mariola Sohngen | 61 | 2020 | CEO & Executive Director |
Denis F. Hochstrasser | - | - | Member of the Scientific Advisory Board |
Roger Steven McDowell | 67 | 2014 | Independent Non Executive Director |
Jean-Charles Sanchez | - | - | Member of the Scientific Advisory Board |
Ursula M. Ney | 70 | 2017 | Independent Non-Executive Director |
Julian Duncan | - | - | Member of Scientific Advisory Board |
Martin H. Diggle | 59 | 2014 | Non-Executive Director |
William Dawson | - | - | Chairman of Scientific Advisory Board |
Brian Anderton | - | - | Member of the Scientific Advisory Board |
Abdelghani Omari | 46 | 2022 | CFO & Director |
Ian H. Pike | - | 2009 | Chief Scientific Officer & Executive Director |
Richard Paul Dennis | 64 | 2017 | Chief Commercial Officer & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review